Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rapport Therapeutics, Inc.

24.99
+0.12000.48%
Post-market: 24.990.00000.00%16:31 EDT
Volume:326.15K
Turnover:8.07M
Market Cap:1.15B
PE:-9.97
High:25.31
Open:24.52
Low:24.25
Close:24.87
52wk High:42.27
52wk Low:6.43
Shares:46.11M
Float Shares:14.96M
Volume Ratio:0.72
T/O Rate:2.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5062
EPS(LYR):-3.7760
ROE:-29.42%
ROA:-20.14%
PB:4.37
PE(LYR):-6.62

Loading ...

Company Profile

Company Name:
Rapport Therapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
2022
Employees:
69
Office Location:
1325 Boylston Street,Suite 401,Boston,Massachusetts,United States
Zip Code:
02215
Fax:
- -
Introduction:
- -

Directors

Name
Position
Abraham N. Ceesay
Chief Executive Officer and Director
Steven M. Paul
Director and Chairman
David Bredt
Chief Scientific Officer and Director
James I. Healy
Director
Jeffrey K. Tong
Director
John Maraganore
Director
Raymond Kelleher
Director
Reid Huber
Director
Terry Ann Burrell
Director

Shareholders

Name
Position
Abraham N. Ceesay
Chief Executive Officer and Director
Cheryl Gault
Chief Operating Officer
Troy Ignelzi
Chief Financial Officer
Bradley S. Galer
Chief Medical Officer
David Bredt
Chief Scientific Officer and Director
Swamy Yeleswaram
Chief Development Officer